Article
Different mutant RUNX1 oncoproteins program alternate haematopoietic differentiation trajectories.
Life science alliance - 1 Feb 2021
Kellaway Sophie G, Keane Peter, Edginton-White Benjamin, Regha Kakkad, Kennett Ella, Bonifer Constanze
Abstract excerpt
Mutations of the haematopoietic master regulator RUNX1 are associated with acute myeloid leukaemia, familial platelet disorder and other haematological malignancies whose phenotypes and prognoses depend upon the class of the RUNX1 mutation. The biochemical behaviour of these oncoproteins and their ability to cause unique diseases has been well studied, but the genomic basis of their differential action is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
